APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meperidine (Demerol)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Meperidine (Demerol) Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchMeperidine (Demerol) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Meperidine (Demerol) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meperidine (Demerol) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meperidine (Demerol) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Meperidine (Demerol) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Meperidine (Demerol) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Meperidine (Demerol) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Meperidine (Demerol) market include Actavis Plc, Boehringer Ingelheim, Egalet, Endo Pharmaceuticals Inc, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, Sun Pharmaceutical Industries Ltd and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meperidine (Demerol) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meperidine (Demerol) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meperidine (Demerol) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meperidine (Demerol) market size, projected growth trends, production technologies, key applications, and end-use industries.

Meperidine (Demerol) Segment by Company

Actavis Plc

Boehringer Ingelheim

Egalet

Endo Pharmaceuticals Inc

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

Sun Pharmaceutical Industries Ltd

Pfizer Inc

Sanofi

Meperidine (Demerol) Segment by Type

Powder

Liquid

Meperidine (Demerol) Segment by Application

Anesthesia

Cough Suppressant

Diarrhea suppressant

Meperidine (Demerol) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Meperidine (Demerol) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Meperidine (Demerol) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Meperidine (Demerol) significant trends, drivers, influence factors in global and regions.

6. To analyze Meperidine (Demerol) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meperidine (Demerol) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meperidine (Demerol) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meperidine (Demerol).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meperidine (Demerol) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Meperidine (Demerol) industry.

Chapter 3: Detailed analysis of Meperidine (Demerol) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Meperidine (Demerol) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Meperidine (Demerol) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Meperidine (Demerol) Industry Trends Table 2. Meperidine (Demerol) Industry Drivers Table 3. Meperidine (Demerol) Industry Opportunities and Challenges Table 4. Meperidine (Demerol) Industry Restraints Table 5. Global Meperidine (Demerol) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Meperidine (Demerol) Revenue Share by Company (2021-2026) Table 7. Global Meperidine (Demerol) Sales Volume by Company (mg) & (2021-2026) Table 8. Global Meperidine (Demerol) Sales Volume Share by Company (2021-2026) Table 9. Global Meperidine (Demerol) Average Price (US$/g) of Company (2021-2026) Table 10. Global Meperidine (Demerol) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Meperidine (Demerol) Key Company Manufacturing Base & Headquarters Table 12. Global Meperidine (Demerol) Company, Product Type & Application Table 13. Global Meperidine (Demerol) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Meperidine (Demerol) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Liquid Table 19. Global Meperidine (Demerol) Sales Volume by Type 2021 VS 2025 VS 2032 (mg) Table 20. Global Meperidine (Demerol) Sales Volume by Type (2021-2026) & (mg) Table 21. Global Meperidine (Demerol) Sales Volume by Type (2027-2032) & (mg) Table 22. Global Meperidine (Demerol) Sales Volume Share by Type (2021-2026) Table 23. Global Meperidine (Demerol) Sales Volume Share by Type (2027-2032) Table 24. Global Meperidine (Demerol) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Meperidine (Demerol) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Meperidine (Demerol) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Meperidine (Demerol) Sales Value Share by Type (2021-2026) Table 28. Global Meperidine (Demerol) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Anesthesia Table 30. Significant Companies of Cough Suppressant Table 31. Significant Companies of Diarrhea suppressant Table 32. Global Meperidine (Demerol) Sales Volume by Application 2021 VS 2025 VS 2032 (mg) Table 33. Global Meperidine (Demerol) Sales Volume by Application (2021-2026) & (mg) Table 34. Global Meperidine (Demerol) Sales Volume by Application (2027-2032) & (mg) Table 35. Global Meperidine (Demerol) Sales Volume Share by Application (2021-2026) Table 36. Global Meperidine (Demerol) Sales Volume Share by Application (2027-2032) Table 37. Global Meperidine (Demerol) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Meperidine (Demerol) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Meperidine (Demerol) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Meperidine (Demerol) Sales Value Share by Application (2021-2026) Table 41. Global Meperidine (Demerol) Sales Value Share by Application (2027-2032) Table 42. Global Meperidine (Demerol) Sales by Region: 2021 VS 2025 VS 2032 (mg) Table 43. Global Meperidine (Demerol) Sales by Region (2021-2026) & (mg) Table 44. Global Meperidine (Demerol) Sales Market Share by Region (2021-2026) Table 45. Global Meperidine (Demerol) Sales by Region (2027-2032) & (mg) Table 46. Global Meperidine (Demerol) Sales Market Share by Region (2027-2032) Table 47. Global Meperidine (Demerol) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Meperidine (Demerol) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Meperidine (Demerol) Sales Value Share by Region (2021-2026) Table 50. Global Meperidine (Demerol) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Meperidine (Demerol) Sales Value Share by Region (2027-2032) Table 52. Global Meperidine (Demerol) Market Average Price (US$/g) by Region (2021-2026) Table 53. Global Meperidine (Demerol) Market Average Price (US$/g) by Region (2027-2032) Table 54. Global Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Table 55. Global Meperidine (Demerol) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 57. Global Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 58. Global Meperidine (Demerol) Sales by Country (2027-2032) & (mg) Table 59. Global Meperidine (Demerol) Sales Market Share by Country (2027-2032) Table 60. Global Meperidine (Demerol) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Meperidine (Demerol) Sales Value Market Share by Country (2021-2026) Table 62. Global Meperidine (Demerol) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Meperidine (Demerol) Sales Value Market Share by Country (2027-2032) Table 64. Actavis Plc Company Information Table 65. Actavis Plc Business Overview Table 66. Actavis Plc Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 67. Actavis Plc Meperidine (Demerol) Product Portfolio Table 68. Actavis Plc Recent Development Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim Meperidine (Demerol) Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Egalet Company Information Table 75. Egalet Business Overview Table 76. Egalet Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Egalet Meperidine (Demerol) Product Portfolio Table 78. Egalet Recent Development Table 79. Endo Pharmaceuticals Inc Company Information Table 80. Endo Pharmaceuticals Inc Business Overview Table 81. Endo Pharmaceuticals Inc Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 82. Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio Table 83. Endo Pharmaceuticals Inc Recent Development Table 84. Janssen Pharmaceuticals Company Information Table 85. Janssen Pharmaceuticals Business Overview Table 86. Janssen Pharmaceuticals Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 87. Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 88. Janssen Pharmaceuticals Recent Development Table 89. Mallinckrodt Pharmaceuticals Company Information Table 90. Mallinckrodt Pharmaceuticals Business Overview Table 91. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 92. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 93. Mallinckrodt Pharmaceuticals Recent Development Table 94. Purdue Pharma Company Information Table 95. Purdue Pharma Business Overview Table 96. Purdue Pharma Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 97. Purdue Pharma Meperidine (Demerol) Product Portfolio Table 98. Purdue Pharma Recent Development Table 99. Sun Pharmaceutical Industries Ltd Company Information Table 100. Sun Pharmaceutical Industries Ltd Business Overview Table 101. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 102. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio Table 103. Sun Pharmaceutical Industries Ltd Recent Development Table 104. Pfizer Inc Company Information Table 105. Pfizer Inc Business Overview Table 106. Pfizer Inc Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 107. Pfizer Inc Meperidine (Demerol) Product Portfolio Table 108. Pfizer Inc Recent Development Table 109. Sanofi Company Information Table 110. Sanofi Business Overview Table 111. Sanofi Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 112. Sanofi Meperidine (Demerol) Product Portfolio Table 113. Sanofi Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Meperidine (Demerol) Distributors List Table 117. Meperidine (Demerol) Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Meperidine (Demerol) Product Image Figure 2. Global Meperidine (Demerol) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Meperidine (Demerol) Sales (2021-2032) & (mg) Figure 5. Global Meperidine (Demerol) Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Meperidine (Demerol) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Liquid Image Figure 11. Global Meperidine (Demerol) Sales Volume by Type (2021 VS 2025 VS 2032) & (mg) Figure 12. Global Meperidine (Demerol) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Meperidine (Demerol) Sales Volume Share by Type (2021-2032) Figure 14. Global Meperidine (Demerol) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Meperidine (Demerol) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Meperidine (Demerol) Sales Value Share by Type (2021-2032) Figure 17. Anesthesia Image Figure 18. Cough Suppressant Image Figure 19. Diarrhea suppressant Image Figure 20. Global Meperidine (Demerol) Sales Volume by Application (2021 VS 2025 VS 2032) & (mg) Figure 21. Global Meperidine (Demerol) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Meperidine (Demerol) Sales Volume Share by Application (2021-2032) Figure 23. Global Meperidine (Demerol) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Meperidine (Demerol) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Meperidine (Demerol) Sales Value Share by Application (2021-2032) Figure 26. Global Meperidine (Demerol) Sales by Region: 2021 VS 2025 VS 2032 (mg) Figure 27. Global Meperidine (Demerol) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Meperidine (Demerol) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Meperidine (Demerol) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Meperidine (Demerol) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Meperidine (Demerol) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Meperidine (Demerol) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Meperidine (Demerol) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Meperidine (Demerol) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Meperidine (Demerol) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Meperidine (Demerol) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Meperidine (Demerol) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Meperidine (Demerol) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Anesthesia
  • Cough Suppressant
  • Diarrhea suppressant
Companies covered
  • Actavis Plc
  • Boehringer Ingelheim
  • Egalet
  • Endo Pharmaceuticals Inc
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • Sun Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meperidine (Demerol) Sales Value (2021-2032)
  4. 1.2.2 Global Meperidine (Demerol) Sales Volume (2021-2032)
  5. 1.2.3 Global Meperidine (Demerol) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Meperidine (Demerol) Market Dynamics
  1. 2.1 Meperidine (Demerol) Industry Trends
  2. 2.2 Meperidine (Demerol) Industry Drivers
  3. 2.3 Meperidine (Demerol) Industry Opportunities and Challenges
  4. 2.4 Meperidine (Demerol) Industry Restraints
3 Meperidine (Demerol) Market by Company
  1. 3.1 Global Meperidine (Demerol) Company Revenue Ranking in 2025
  2. 3.2 Global Meperidine (Demerol) Revenue by Company (2021-2026)
  3. 3.3 Global Meperidine (Demerol) Sales Volume by Company (2021-2026)
  4. 3.4 Global Meperidine (Demerol) Average Price by Company (2021-2026)
  5. 3.5 Global Meperidine (Demerol) Company Ranking (2024-2026)
  6. 3.6 Global Meperidine (Demerol) Company Manufacturing Base and Headquarters
  7. 3.7 Global Meperidine (Demerol) Company Product Type and Application
  8. 3.8 Global Meperidine (Demerol) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Meperidine (Demerol) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Meperidine (Demerol) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Meperidine (Demerol) Market by Type
  1. 4.1 Meperidine (Demerol) Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Meperidine (Demerol) Sales Volume by Type
  5. 4.2.1 Global Meperidine (Demerol) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Meperidine (Demerol) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Meperidine (Demerol) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Meperidine (Demerol) Sales Value by Type
  9. 4.3.1 Global Meperidine (Demerol) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Meperidine (Demerol) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Meperidine (Demerol) Sales Value Share by Type (2021-2032)
5 Meperidine (Demerol) Market by Application
  1. 5.1 Meperidine (Demerol) Application Introduction
  2. 5.1.1 Anesthesia
  3. 5.1.2 Cough Suppressant
  4. 5.1.3 Diarrhea suppressant
  5. 5.2 Global Meperidine (Demerol) Sales Volume by Application
  6. 5.2.1 Global Meperidine (Demerol) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meperidine (Demerol) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Meperidine (Demerol) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Meperidine (Demerol) Sales Value by Application
  10. 5.3.1 Global Meperidine (Demerol) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Meperidine (Demerol) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Meperidine (Demerol) Sales Value Share by Application (2021-2032)
6 Meperidine (Demerol) Regional Sales and Value Analysis
  1. 6.1 Global Meperidine (Demerol) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meperidine (Demerol) Sales by Region (2021-2032)
  3. 6.2.1 Global Meperidine (Demerol) Sales by Region: 2021-2026
  4. 6.2.2 Global Meperidine (Demerol) Sales by Region (2027-2032)
  5. 6.3 Global Meperidine (Demerol) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Meperidine (Demerol) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Meperidine (Demerol) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Meperidine (Demerol) Sales Value by Region (2027-2032)
  9. 6.5 Global Meperidine (Demerol) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Meperidine (Demerol) Sales Value (2021-2032)
  12. 6.6.2 North America Meperidine (Demerol) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Meperidine (Demerol) Sales Value (2021-2032)
  15. 6.7.2 Europe Meperidine (Demerol) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Meperidine (Demerol) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Meperidine (Demerol) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Meperidine (Demerol) Sales Value (2021-2032)
  21. 6.9.2 South America Meperidine (Demerol) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Meperidine (Demerol) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Meperidine (Demerol) Sales Value Share by Country, 2025 VS 2032
7 Meperidine (Demerol) Country-level Sales and Value Analysis
  1. 7.1 Global Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Meperidine (Demerol) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Meperidine (Demerol) Sales by Country (2021-2032)
  4. 7.3.1 Global Meperidine (Demerol) Sales by Country (2021-2026)
  5. 7.3.2 Global Meperidine (Demerol) Sales by Country (2027-2032)
  6. 7.4 Global Meperidine (Demerol) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Meperidine (Demerol) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Meperidine (Demerol) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Meperidine (Demerol) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Meperidine (Demerol) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Meperidine (Demerol) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis Plc
  2. 8.1.1 Actavis Plc Company Information
  3. 8.1.2 Actavis Plc Business Overview
  4. 8.1.3 Actavis Plc Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Plc Meperidine (Demerol) Product Portfolio
  6. 8.1.5 Actavis Plc Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Meperidine (Demerol) Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Egalet
  14. 8.3.1 Egalet Company Information
  15. 8.3.2 Egalet Business Overview
  16. 8.3.3 Egalet Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Egalet Meperidine (Demerol) Product Portfolio
  18. 8.3.5 Egalet Recent Developments
  19. 8.4 Endo Pharmaceuticals Inc
  20. 8.4.1 Endo Pharmaceuticals Inc Company Information
  21. 8.4.2 Endo Pharmaceuticals Inc Business Overview
  22. 8.4.3 Endo Pharmaceuticals Inc Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio
  24. 8.4.5 Endo Pharmaceuticals Inc Recent Developments
  25. 8.5 Janssen Pharmaceuticals
  26. 8.5.1 Janssen Pharmaceuticals Company Information
  27. 8.5.2 Janssen Pharmaceuticals Business Overview
  28. 8.5.3 Janssen Pharmaceuticals Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio
  30. 8.5.5 Janssen Pharmaceuticals Recent Developments
  31. 8.6 Mallinckrodt Pharmaceuticals
  32. 8.6.1 Mallinckrodt Pharmaceuticals Company Information
  33. 8.6.2 Mallinckrodt Pharmaceuticals Business Overview
  34. 8.6.3 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio
  36. 8.6.5 Mallinckrodt Pharmaceuticals Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Meperidine (Demerol) Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Sun Pharmaceutical Industries Ltd
  44. 8.8.1 Sun Pharmaceutical Industries Ltd Company Information
  45. 8.8.2 Sun Pharmaceutical Industries Ltd Business Overview
  46. 8.8.3 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
  49. 8.9 Pfizer Inc
  50. 8.9.1 Pfizer Inc Company Information
  51. 8.9.2 Pfizer Inc Business Overview
  52. 8.9.3 Pfizer Inc Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Inc Meperidine (Demerol) Product Portfolio
  54. 8.9.5 Pfizer Inc Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Meperidine (Demerol) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Meperidine (Demerol) Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meperidine (Demerol) Value Chain Analysis
  2. 9.1.1 Meperidine (Demerol) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meperidine (Demerol) Sales Mode & Process
  6. 9.2 Meperidine (Demerol) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meperidine (Demerol) Distributors
  9. 9.2.3 Meperidine (Demerol) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst